What is Merck & Company Inc?
operates as a healthcare company worldwide.
0QAH · Verdict
Moderate reward · low risk
0QAH stands out on volatility and cash flow, but watch the valuation signal.
Based on 88% data coverage
0QAH · Verdict
Top decile vs peers
19% free-cash-flow margin
28% net margin · 7% ROE
P/E 55.2× · PEG 10.43
Rev +3.1% CAGR · earnings +7.9%
Model-based scoring. For information only — not financial advice.
operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company is listed on the LSE in UK, with a market capitalisation of 384.04B, and a P/E ratio of 0.2x.
The scoring profile indicates limited reward potential at this time, with profitability and momentum offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.